Organigram FY2024 EPS Lifted by Alliance Global Partners

Organigram Holdings Inc. (NASDAQ:OGIFree Report) – Analysts at Alliance Global Partners upped their FY2024 earnings estimates for shares of Organigram in a note issued to investors on Monday, December 9th. Alliance Global Partners analyst A. Grey now expects that the company will earn ($0.18) per share for the year, up from their previous estimate of ($0.19). The consensus estimate for Organigram’s current full-year earnings is ($0.21) per share. Alliance Global Partners also issued estimates for Organigram’s Q4 2024 earnings at ($0.02) EPS, Q2 2025 earnings at ($0.01) EPS, Q3 2025 earnings at ($0.01) EPS, Q4 2025 earnings at ($0.01) EPS and FY2025 earnings at ($0.02) EPS.

Organigram Trading Down 2.5 %

OGI stock opened at $1.54 on Wednesday. The firm’s 50-day moving average is $1.65 and its two-hundred day moving average is $1.68. Organigram has a 52 week low of $1.20 and a 52 week high of $2.91. The company has a market capitalization of $167.73 million, a price-to-earnings ratio of -3.67 and a beta of 1.02.

Hedge Funds Weigh In On Organigram

A number of hedge funds and other institutional investors have recently modified their holdings of OGI. Tidal Investments LLC boosted its position in Organigram by 8.3% during the 3rd quarter. Tidal Investments LLC now owns 1,948,188 shares of the company’s stock worth $3,526,000 after acquiring an additional 149,171 shares during the period. AdvisorShares Investments LLC increased its stake in shares of Organigram by 11.8% in the second quarter. AdvisorShares Investments LLC now owns 1,000,126 shares of the company’s stock worth $1,540,000 after acquiring an additional 105,468 shares during the last quarter. Renaissance Technologies LLC raised its holdings in shares of Organigram by 40.8% during the second quarter. Renaissance Technologies LLC now owns 816,948 shares of the company’s stock worth $1,258,000 after acquiring an additional 236,700 shares in the last quarter. Baader Bank Aktiengesellschaft boosted its position in Organigram by 26.4% during the second quarter. Baader Bank Aktiengesellschaft now owns 252,852 shares of the company’s stock valued at $388,000 after purchasing an additional 52,852 shares during the last quarter. Finally, Canton Hathaway LLC grew its stake in Organigram by 115.8% in the second quarter. Canton Hathaway LLC now owns 41,000 shares of the company’s stock valued at $63,000 after purchasing an additional 22,000 shares in the last quarter. Institutional investors and hedge funds own 34.63% of the company’s stock.

Organigram Company Profile

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

See Also

Earnings History and Estimates for Organigram (NASDAQ:OGI)

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.